Daniil Kalyuzhny currently serves as Managing Director at BTIG, where he leverages his extensive expertise in global healthcare, particularly within the life sciences tools, diagnostics, and medical technology sectors. With a robust track record of origination and execution, Daniil has been instrumental in facilitating approximately...
Daniil Kalyuzhny currently serves as Managing Director at BTIG, where he leverages his extensive expertise in global healthcare, particularly within the life sciences tools, diagnostics, and medical technology sectors. With a robust track record of origination and execution, Daniil has been instrumental in facilitating approximately $20 billion in transactions, encompassing both mergers and acquisitions (M&A) and financing activities. His role involves advising boards of directors and management teams, guiding them through complex strategic evaluations and helping them navigate investment and transaction alternatives that align with their long-term objectives.
At BTIG, Daniil is deeply involved in key projects that drive innovation and growth within the healthcare landscape. His analytical skills and financial acumen enable him to conduct thorough valuations and financial analyses, ensuring that clients are equipped with the insights necessary to make informed decisions. Daniil’s previous experience as a Senior Associate at Blackstone (BAAM) further honed his abilities in hedge fund management and investment strategies, enriching his perspective on the financial dynamics that underpin the healthcare sector.
Daniil's proficiency in accounting, finance, and management, combined with his adept use of Microsoft Office tools, positions him as a vital asset in the fast-paced world of healthcare investment banking. His commitment to excellence and strategic foresight not only enhances client relationships but also fosters an environment of trust and collaboration, ultimately driving successful outcomes in a rapidly evolving industry.
